- Home
- / 23andMe
23andMe
Stock Price
$0.5
2024-05-08
Market Capitalization
$146.4 M
2024-04-27
Revenue
$299.5 M
FY, 2023
23andMe Summary
Company Summary
- Overview
- 23andMe Holding (formerly known as VG Acquisition Corp) is a consumer genetics and research company. It aims to help individuals to understand their own genetic information through DNA analysis technologies and web-based interactive tools. The сompany enables people to gain insights into their ancestry and genetic makeup.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://www.23andme.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Kathy Hibbs, Chief Administrative Officer
Kenneth Hillan, Chief Therapeutics Officer
Jeffrey Pollard, Director of Medical Affairs
Operating MetricsView all
Countries
50
Apr, 2020
Customers
10M
Apr, 2020
DNA Kits Sold
10M
Feb, 2020
23andMe Financials
Summary Financials
- Revenue (Q3, 2024)
- $44.7M
- Gross profit (Q3, 2024)
- $19.9M
- Net income (Q3, 2024)
- ($278.0M)
- Cash (Q3, 2024)
- $242.4M
- EBIT (Q3, 2024)
- ($281.2M)
- Enterprise value
- ($17.2M)